Latest Manufacturing News

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Structural Monitoring Systems’ Canadian subsidiary has landed a $900,500 order from CAL FIRE for 50 advanced firefighting radios, marking a significant step in a broader fleet upgrade program.

Li-S Energy has successfully produced Australia’s first lithium metal foils ahead of schedule at its Geelong facility, marking a major step in domestic battery manufacturing and supply chain sovereignty.

AML3D Limited has confirmed it complied with ASX continuous disclosure rules regarding its recent Letter of Intent with the US Navy, clarifying the timing of its awareness and announcement.

Yowie Group has decided not to proceed with its planned takeover bid for Keybridge Capital after a key condition was triggered, signaling a strategic retreat.

Chariot Corporation Ltd is set to acquire a 66.7% interest in a substantial Nigerian lithium portfolio, marking a strategic entry into Africa’s burgeoning lithium sector with a US$10 million funding commitment.

Buxton Resources has successfully qualified its Graphite Bull ore for full anode production with BTR New Material Group, a global leader in battery anode manufacturing. This milestone strengthens the project’s commercial appeal amid rising graphite demand for lithium-ion batteries.

ClearVue Technologies and LandGlass subsidiary LandVac have entered a strategic partnership to co-develop and commercialize advanced solar vacuum insulated glazing products, aiming to revolutionize energy-efficient building materials worldwide.

Sparc Technologies progresses its pioneering green hydrogen pilot plant and graphene-based coatings, backed by a significant government grant and a successful capital raise.

American Rare Earths reports high recoveries of key rare earth elements and significantly reduced impurities at its Halleck Creek project, marking a major step in its path to U.S. rare earth independence.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.